A new report has revealed some key 2023 cannabis trends. Key among them is the growing use of cannabis in medicine, stress management, and well-being. There is also the rise of cannabis in food products, including oils, beverages, and snacks. Finally, there are also promising signs that cannabis is emerging as a life-saving alternative to destructive alcohol consumption habits.
It is no secret that achieving success in the cannabis industry is challenging. High entry barriers, costly licenses, and overly restrictive regulations have posed significant challenges for those attempting to succeed. One of the best ways to meet these challenges is by tracking trends related to cannabis products, the industry, and consumers.
The legacy of prohibition impacts all of these areas, and analyzing industry trends in this context is necessary. The Cannabis Trends 2023 report published by New Frontiers Data not only reviews trends in the cannabis industry but also seeks to educate industry professionals about the impact of prohibition on these trends. By understanding where we come from, we can adopt the right strategy and effectively move forward.
For more news like this, download our free cannabis news app.
Years of cannabis prohibition have created a “feast or famine” mentality among consumers and a desire to stick to what they know. Historically, buying cannabis on the black market meant purchasing flowers, and concerns about availability meant that higher potency was considered the best. After all, the risk of obtaining an illegal product and spending time and money on flower that wasn’t consistently available led consumers to seek the strongest cannabis strains to save money.
As a result, higher THC strains were preferred by growers and sellers because they commanded higher prices in the market. CBD-rich cannabis would be classified as lower quality and have a lower price, and therefore were almost eliminated. And while legalization removed criminal penalties and allowed consumers safe and legal access to cannabis, the early years of legalization showed that old habits die hard.
High THC content was still associated with high quality, and flowers remained the primary form of cannabis products purchased by consumers. However, as people begin to relax in the new reality of legal cannabis, and companies develop more advanced products to meet specific needs, we are witnessing the emergence of two trends: the evolution of preferred forms beyond flowers and the growing popularity of lower THC concentration products.
A study from 2008 conducted on 350 medical cannabis patients revealed that 53% of them used cannabis as a substitute for alcohol. And 15 years later, in a New Frontier Data Consumer study conducted on nearly 4,000 current consumers, 57% of them reported replacing at least part of their alcohol consumption with cannabis. This was more pronounced among younger consumers, with 66% of individuals aged 25-34 using cannabis as a substitute for alcohol.
According to a recent Berenberg Research report, Generation Z consumes 20% less alcohol than millennials did at their age. And according to our data, they are the most frequent cannabis consumers, with 44.1% reporting daily usage. Younger consumers are the least likely to engage in daily alcohol consumption and are more likely than those aged 25-44 to claim they never drink. Additionally, the most common drinking pattern among all age groups is drinking several times a week, except for individuals aged 18-24, who most commonly report drinking several times a month.
Substituting alcohol with cannabis is prevalent across all age groups. Overall, 56.8% of consumers claim to have replaced at least part of their alcohol consumption with cannabis. Non-alcoholic beers are a rapidly growing segment in the alternative alcohol market, and cannabis-infused beverages are emerging alongside them. Transactions in dispensaries involving beverages steadily increased between January 2020 and March 2023.
Further bolstering interest in alternatives to alcohol, a recent World Health Organization report states that there is no “safe” level of alcohol consumption, challenging previous claims that moderate drinking can have health benefits. For consumers who wish to avoid alcohol but still enjoy an altered state of consciousness, cannabis-infused beverages can be a good choice.
However, early cannabis-infused beverages had a duration of action similar to edible products and faced issues with taste and proper dosage. The development of the industry has taken THC-infused beverages to a higher level, making them a real alternative to alcohol. Firstly, in order to realistically replace alcohol, cannabis-infused beverages had to address the issue of delayed onset. The onset of effects occurring 1-2 hours later, as seen with THC-infused edibles, made beverages unappealing in social situations where alcohol was also served.
However, the introduction of nanoemulsion technology, in which cannabinoids are reduced to sizes small enough for rapid absorption into the bloodstream, has lowered the onset time from 1-2 hours to 10-15 minutes. This allows consumers to consume their dose in a manner they are accustomed to from their alcohol experiences. Secondly, they taste better. Cannabis oil can leave a bitter taste that was unappealing to many consumers. Today’s beverages feature unique and interesting flavor profiles that better mask bitterness.
Finally, cannabis trends in the beverage market have adapted to consumers. In many early beverages, attempts were made to cram enough THC into a bottle to satisfy heavy consumers. While cans and bottles containing 100 mg of THC can still be found, more frequently, higher-dose products take the form of flavored shots and additives that allow the consumer to craft their own potent beverage. Most newer cannabis-infused beverages are leaning towards lower doses.
For cannabis as a substitute for alcohol, low dosage makes sense for many consumers, as they may want to consume two or three beverages during an event, which, at 5-10 mg of THC per serving, provides a pleasant and controllable experience. Furthermore, with the rise of cannabis consumption in hotels and consumer-friendly establishments, beverages offer an enjoyable and interesting way to deliver THC without smoking and without the risk associated with edibles, which, due to delayed onset, are more likely to cause an overdose in inexperienced consumers.
In discussions about cannabinoids, THC and CBD used to dominate the conversation. Indeed, they are the two most prevalent cannabinoids found in cannabis. However, there are over 90 cannabinoids (and counting!) that occur in smaller quantities, including THCV, CBDV, CBC, CBG, and CBN. And while research on the potential benefits of these novel cannabinoids is still in its early stages, brands and consumers are intrigued, and more products are incorporating these compounds into their formulations.
The presence of terpenes and novel cannabinoids can enhance certain effects of cannabis and provide consumers with a better sense of what to expect. With increasingly advanced laboratory testing, labels featuring terpene profiles and cannabinoid content have become more commonplace.
Interest in lesser-known cannabinoids and terpenes was highest among individuals aged 25-44 and among men. Interestingly, this age group was also the most likely to say that these factors were not important to them. Younger consumers aged 18-24 were less likely to say that these factors influenced their decision, but they were the most likely to at least want to know what a lesser-known cannabinoid or terpene is and the most likely to say they have access to that information.
Knowledge about cannabinoids derived from cannabis, such as Delta-8 THC, THC-O, and THCP, was most widespread among younger consumers and men. Knowledge about lesser-known cannabinoids like THCV, THCA, CBC, and others was highest among individuals aged 25-44 and among men. This age group of 25-44 was also the most likely to report that these compounds are important in their purchasing decisions.
This may be due to the fact that this age group is more willing to try new products compared to older age groups. It is worth noting that very few consumers in different age groups have not heard of any of the mentioned compounds. Knowledge about cannabinoids derived from cannabis was highest in illicit markets where access to regulated cannabis products does not exist.
Nearly 60% of consumers in illicit markets have heard of Delta-8 THC, compared to 52.5% in strictly medical markets and 42.2% in adult-use markets. Individuals in strictly medical markets were the most likely to be familiar with lesser-known non-psychoactive cannabinoids such as CBC, CBG, and CBDV.
These patterns generally hold true for both consumers and non-consumers. The number of transactions involving products containing lesser-known cannabinoids has been increasing since 2020. The most significant growth can be observed in products containing CBN. Although research is still in its early stages, CBN has gained a reputation as a sleep-supportive compound and has started appearing in sleep-promoting products. This indicates a consumer desire for products that deliver specific effects. We are also seeing an increase in the number of products with lesser-known cannabinoids being sold in dispensaries. In addition to CBN, we are witnessing the emergence of CBG and THCV, with the latter being promoted as an appetite suppressant (again, research in this area is still developing).
To summarize the key 2023 cannabis trends, here is how different markets are evolving.
You can obtain the full report here.
—
(Featured illustration by Kindel Media via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…